Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive neuropathy and cardiomyopathy.
TTR is synthesized primarily by the liver, with <5% synthesized in the choroid plexus of the brain and the retinal pigment epithelium. TTR has important roles in behavior, cognition, nerve regeneration, and axonal growth (2) . TTR has an innate ability to aggregate into insoluble amyloid fibers. Transient accumulation of TTR oligomers, composed of 6 to 10 monomers, may cause cell toxicity or tissue damage.
Single point mutations can increase the likelihood of TTR misfolding into an insoluble b-pleated sheet, which deposits in the heart, nerves, and other tissues, causing familial amyloid cardiomyopathy, familial amyloid polyneuropathy (FAP), and leptomeningeal amyloidosis (3, 4) . Table 1 provides the most common mutations recently reported from a single U.S. center.
More than 80 TTR mutations have been described, including the nonpathogenic G6S mutation found in 6% of the white population. V30M is the second most common mutation in the United States, but, to date, it is the most frequent reported globally. Three major clusters in Portugal, Sweden, and Japan have been described. The Portuguese and Japanese appear to have a single founder in the 15th century (brought from Portugal to Japan by explorers) (5, 6) . The V30M mutation seems to have appeared later in Sweden than in Portugal and Japan (7) . The largest populations of mutant TTR, V30M (p.V50M), are in endemic areas of Japan, Sweden, and Portugal, with large cohorts in Brazil (8) . The Wild-type (wt) TTR can also misfold into the amyloid configuration. Previously termed senile cardiac amyloidosis and subsequently as senile systemic amyloidosis, wt TTR amyloidosis will be called wt transthyretin amyloidosis (ATTR) in this paper. Wt ATTR is sporadic, with no known biomarkers for its diagnosis. Deposition of the wt protein occurs almost exclusively (90%) in men >60 years of age.
CLINICAL CHARACTERISTICS OF CARDIAC AMYLOIDOSIS
Amyloid infiltration results in poor diastolic relaxation (poor filling, with low end-diastolic volume).
Doppler measures of inflow velocity can detect left ventricular diastolic filling abnormalities, and
Doppler diastolic filling variables are prognostic in cardiac amyloidosis. Shortened deceleration time and an increased early diastolic filling velocity to atrial filling velocity ratio are stronger predictors of cardiac death (9) . Amyloid cardiomyopathy should be suspected in any patient who presents with heart failure and preserved ejection fraction. Findings of right-sided heart failure predominate, including lower-extremity edema, hepatomegaly, ascites, and elevated jugular pressure. Right ventricular dilation is linked to more severe cardiac involvement and short survival (median 4 months) (10) . A study of 74 patients with biopsy-proven immunoglobulin light chain (AL) amyloidosis showed an association of right ventricular dysfunction with more severe involvement of the left ventricle, higher plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), and poor prognosis (11) .
Using strain echocardiography, left atrial dysfunction was identified in 32% (lateral left atrial criteria) and 60% (septal left atrial criteria) of patients with amyloidosis (12) . Severe atrial and ventricular infiltration by amyloid may result in mechanical atrial standstill, with resultant thrombus formation (13) .
These findings have been identified by cardiac magnetic resonance (CMR) imaging (14) . CMR has also been used to estimate cardiac amyloid burden by quantification of myocardial extracellular volume fraction (15) . In addition to heart failure, patients may present with atrial arrhythmias or conduction system disease. In patients who have ventricular thickening without a history of hypertension or valvular disease, an infiltrative cardiomyopathy should be considered (16) . Deposition of amyloid into the myocardial wall causes diastolic dysfunction, restrictive physiology with late loss of systolic function, arrhythmias, and heart failure (17) . The finding of increased wall thickness, small ventricular volume, and occasional dynamic left ventricular outflow tract obstruction can be confused with true hypertrophic conditions such as hypertrophic cardiomyopathy and hypertensive heart disease. Although the electrocardiogram classically shows low voltage in the QRS complex in amyloidosis and increased voltage in myocyte hypertrophy disorders, the overlap is great; voltage can be useful but is not reliable (18, 19) . Clinical presentation of mutant ATTR is variable and driven by the specific mutation, of which w110 have been described. Patients with mutant ATTR present on a spectrum from exclusive neuropathy to cardiomyopathy-overlapping phenotypes. Among 611 symptomatic patients with hereditary TTR, multisystem involvement was seen with each mutation (21) . The quality of life in patients with hereditary ATTR is severely impaired.
GENERAL CHARACTERISTICS OF TTR AMYLOIDOSIS
In a study of ATTR cardiomyopathy, 212 of 266 patients were men (80%) (22) The natural history of wt ATTR is much better than other forms of amyloid cardiomyopathy (19) . In 1 of the first studies, the median survival was 60 months from presentation with heart failure symptoms, whereas it was 5.4 months for patients with cardiomyopathy from AL amyloidosis (27) . Characteristics of wt ATTR include greater left ventricular wall thickness than that of patients with AL amyloidosis, less-severe heart failure, and a median survival of 75 versus 11 months, again suggesting a more protracted clinical course (28) . Despite the long clinical course of heart failure, the disease is progressive with time.
Echocardiography, 6-min walk, and NT-proBNP revealed significant declines in myocardial performance over a 6-month observation period (29) . In a large series of more than 100 patients with wt ATTR, median survival from onset of symptoms was 6.07
years. Predictors of shorter survival included troponin elevation, the need for a pacemaker, and elevation of New York Heart Association functional class (30 for ATTR, and DPD was proposed as a useful diagnostic component for distinguishing between forms of cardiac amyloidosis ( Figure 4) . However, the same group later reported that although 99m Tc-DPD scintigraphy could be useful for differentiating ATTR from AL amyloidosis-related cardiomyopathy, its diagnostic accuracy was lower than previously reported because of a mild degree of tracer uptake in about one-third of patients with AL amyloidosis (55).
Another publication from the same group reported Amyloid infiltration causing wall thickening.
Gertz et al. Digoxin binds to amyloid fibrils and can lead to locally high levels; it also must be used with caution (78, 79) . combined heart and liver transplant had better survival than those with heart transplantation alone. This Isolated heart transplantation has also been performed. It may be particularly beneficial for the patients with the V122I TTR mutation, which has late onset and often does not deposit outside of the heart.
In a case report, no systemic abnormalities were Table 2) .
Tafamidis also prevents biochemical and echocardiographic decline in TTR cardiomyopathy (120).
Ten years ago, studies showed that small interfering ribonucleic acid (siRNA) could selectively silence V30M TTR gene expression in cell culture systems (121) . Advances in siRNA delivery and target selection provided the opportunity to initiate human trials using this technology (122 Gertz et al. 
